 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 December 1993 | Volume 119 Issue 11 | Pages 1093-1104
Objective: To compare the pathogenesis, clinical presentation, therapy, and prognosis of primary central nervous system lymphoma in immunocompetent persons with these characteristics of the disease in patients with AIDS.
Data Sources and Extraction: All English-language papers published between 1980 and 1992 dealing with either lymphoma and the central nervous system or AIDS were reviewed. Patient characteristics, clinical presentation, histologic findings, and treatment and survival data were extracted from each case report and review.
Data Synthesis: Data were available on 792 patients (from 40 reported series) with non-AIDS-associated primary central nervous system lymphoma and 315 patients (from 32 series) with AIDS-associated primary central nervous system lymphoma. Patients with AIDS initially consulted a physician more often when they had global neurologic symptoms compared with patients without AIDS, with more than 50% of the lesions on computed tomographic (CT) scans in patients with AIDS being ring-enhancing and multifocal, a pattern rarely described in immunocompetent patients. The overall survival of the patients without AIDS was 18.9 months compared with 2.6 months for patients with AIDS, with substantial differences remaining even for subgroups of patients similarly treated with radiation and chemotherapy.
Conclusion: Primary central nervous system lymphoma is probably a substantially different disease in persons with and without AIDS with regard to patient characteristics, clinical and radiographic presentation, and prognosis. Recent advances in the treatment of this disease in patients without AIDS have not largely affected patients with AIDS. Substantial improvements in survival in these patients await advances in controlling their human immunodeficiency virus-associated disease.
Author and Article Information
From the Dana-Farber Cancer Institute, The Brain Tumor Center, The Brigham and Women's Hospital, and Harvard Medical School, Boston Massachusetts.
REVIEW
Primary Central Nervous System Lymphoma
Requests for Reprints: Howard A. Fine, MD, Division of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115.
Acknowledgments: The authors thank Mary B. Fishman, MD, and George P. Canellos, MD, for review of the manuscript; Alexandra M. Levine, MD, for useful discussions; Rebecca Folkerth, MD, and Jerrold Turner MD, PhD, for contribution of the photomicrographs; and James Suojanen, MD, for the radiographs.
This article has been cited by other articles:
|
|
 |
|
  K. Jahnke, M. Hummel, A. Korfel, T. Burmeister, P. Kiewe, H. A. Klasen, H.-H. Muller, H. Stein, and E. Thiel Detection of Subclinical Systemic Disease in Primary CNS Lymphoma by Polymerase Chain Reaction of the Rearranged Immunoglobulin Heavy-Chain Genes J. Clin. Oncol., October 10, 2006; 24(29): 4754 - 4757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Rubenstein, J. Fridlyand, A. Shen, K. Aldape, D. Ginzinger, T. Batchelor, P. Treseler, M. Berger, M. McDermott, M. Prados, et al. Gene expression and angiotropism in primary CNS lymphoma Blood, May 1, 2006; 107(9): 3716 - 3723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Batchelor and J. S. Loeffler Primary CNS Lymphoma J. Clin. Oncol., March 10, 2006; 24(8): 1281 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Jahnke, A. Schilling, J. Heidenreich, H. Stein, M. Brock, E. Thiel, and A. Korfel Radiologic Morphology of Low-Grade Primary Central Nervous System Lymphoma in Immunocompetent Patients AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2446 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Coupland, C. Loddenkemper, J. R. Smith, R. M. Braziel, F. Charlotte, I. Anagnostopoulos, and H. Stein Expression of Immunoglobulin Transcription Factors in Primary Intraocular Lymphoma and Primary Central Nervous System Lymphoma Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 3957 - 3964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vernino, D. R. Salomao, T. M. Habermann, and B. P. O'Neill Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil Neurology, August 23, 2005; 65(4): 639 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Harder, H. Holtel, J. E.C. Bromberg, P. Poortmans, H. Haaxma-Reiche, H. C. Kluin-Nelemans, J. Menten, and M. J. van den Bent Cognitive status and quality of life after treatment for primary CNS lymphoma Neurology, February 24, 2004; 62(4): 544 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M.P. Poortmans, H. C. Kluin-Nelemans, H. Haaxma-Reiche, M. Van't Veer, M. Hansen, P. Soubeyran, M. Taphoorn, J. Thomas, M. Van den Bent, M. Fickers, et al. High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non-AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962 J. Clin. Oncol., December 15, 2003; 21(24): 4483 - 4488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.M. Ferreri, J.-Y. Blay, M. Reni, F. Pasini, M. Spina, A. Ambrosetti, A. Calderoni, A. Rossi, V. Vavassori, A. Conconi, et al. Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience J. Clin. Oncol., January 15, 2003; 21(2): 266 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Rubenstein, D. Combs, J. Rosenberg, A. Levy, M. McDermott, L. Damon, R. Ignoffo, K. Aldape, A. Shen, D. Lee, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment Blood, January 15, 2003; 101(2): 466 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Otieno, C. Banura, E. Katongole-Mbidde, J. L. Johnson, M. Ghannoum, A. Dowlati, R. Renne, E. Arts, C. Whalen, M. M. Lederman, et al. Therapeutic Challenges of AIDS-Related Non-Hodgkin's Lymphoma in the United States and East Africa J Natl Cancer Inst, May 15, 2002; 94(10): 718 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. M. Ferreri, J.-Y. Blay, M. Reni, F. Pasini, A. Gubkin, U. Tirelli, A. Calderoni, E. Zucca, S. Cortelazzo, C. Chassagne, et al. Relevance of intraocular involvement in the management of primary central nervous system lymphomas Ann. Onc., April 1, 2002; 13(4): 531 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Al-Shahi, C P Warlow, G H Jansen, C. Frijns, and J van Gijn A 59 year old man with progressive spinal cord and peripheral nerve dysfunction culminating in encephalopathy: Edinburgh advanced clinical neurology course, 1999 J. Neurol. Neurosurg. Psychiatry, November 1, 2001; 71(5): 696 - 703. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Giustina, M. Gola, M. Doga, and E. A. Rosei Primary Lymphoma of the Pituitary: An Emerging Clinical Entity J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4567 - 4575. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Gallagher, Z. Wang, M. J. Schymura, A. Kahn, and E. J. Fordyce Cancer Incidence in New York State Acquired Immunodeficiency Syndrome Patients Am. J. Epidemiol., September 15, 2001; 154(6): 544 - 556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Fine, W. D. Figg, K. Jaeckle, P. Y. Wen, A. P. Kyritsis, J. S. Loeffler, V. A. Levin, P. M. Black, R. Kaplan, J. M. Pluda, et al. Phase II Trial of the Antiangiogenic Agent Thalidomide in Patients With Recurrent High-Grade Gliomas J. Clin. Oncol., February 14, 2000; 18(4): 708 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ng, M. A. Rosenthal, D. Ashley, and L. Cher High-dose methotrexate for primary CNS lymphoma in the elderly Neuro-oncol, January 1, 2000; 2(1): 40 - 44. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Julien, M. Radosavljevic, N. Labouret, S. Camilleri-Broet, F. Davi, M. Raphael, T. Martin, and J.-L. Pasquali AIDS Primary Central Nervous System Lymphoma: Molecular Analysis of the Expressed VH Genes and Possible Implications for Lymphomagenesis J. Immunol., February 1, 1999; 162(3): 1551 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Brecher, F. H Hochberg, D. N Louis, S. de la Monte, and P. Riskind Case report of unusual leukoencephalopathy preceding primary CNS lymphoma J. Neurol. Neurosurg. Psychiatry, December 1, 1998; 65(6): 917 - 920. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Samuels and S. de la Monte Case 36-1994- A 49-Year-Old Man with Hypopituitarism, Multifocal Neurologic Defects, and an Intracranial Mass N. Engl. J. Med., September 29, 1994; 331(13): 861 - 868. [Full Text]
|
|
Article
